The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes

Enrico Maggi1, Nadine Landolina1, Francesca Romana Mariotti1

  • 1Tumor Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Frontiers in Immunology
|October 23, 2025
PubMed